// App-Quantinova.ai

BSH19‐EP‐009 : The impact of the BSH 2018 polycythaemia vera guidelines on clinical management in the Sheffield and Barnsley catchment area

Researchers

Presenter

  • S. Francis

Principal Investigators

  • Y. Sorour

  • S. Keat

Medical Centers

  • Haematology Department, Haematology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield

  • Haematology Department, Barnsley District General Hospital, Barnsley, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Essential thrombocythemia

  • Extreme thrombocytosis

  • Polycythaemia vera

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxycarbamide

  • Erythropoietin

  • Interferon

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved